Deep connections drive psychedelic research

As psychedelic drugs gain more support from the medical community as a potential treatment for severe depression, Cornell researchers are making crucial discoveries that explain how compounds such as psilocybin work on the brain.

607-255-6074mediarelations@cornell.edu

Tip Sheets

Expert Quotes

Featured Video

In this episode of Research Matters, psychologist Gordon Pennycook dives into the surprisingly relatable science of why smart people believe dumb things.

In The News

INC.

Cornell University assistant computer science professor John Thickstun commented on the marketing motives behind AI safety narratives.

Associated Press

Miguel Gomez, a Cornell University professor, discussed how $100-per-barrel oil increases food prices through supply chain effects.

The Hill

Cornell government professor Steve Israel argues that President Trump’s revived election-fraud rhetoric and regal White House renovations are warnings that his administration may seek to exploit political chaos and undermine democratic institutions ahead of the 2026 midterms.

Forbes

Chekitan Dev, a professor at Cornell's Nolan School of Hotel Administration, describes soft hotel brands as a 'genius' model for the hospitality industry.

CNBC

Cornell University is conducting a clinical trial for GLP-1 weight-loss drugs in overweight cats.

Gizmodo

Paige Cunningham, an assistant professor in the Division of Nutritional Sciences at Cornell, co-authored research on how drinking water with meals can increase calorie intake.